Colon Cancer Treatment - AMDL Confirms Special Shareholders Meeting in September
AMDL Confirms Special Shareholders Meeting in September
[Press Release] PR Newswire via Yahoo! Finance - Jul 27 12:18 PM
AMDL, Inc. , developer and marketer of tests for the early detection of cancer and other serious diseases, today said that a shareholder notice and proxy statement is being mailed this week to shareholders regarding a Special Meeting to be held on September 8, 2006, at 10 a.m. at the Hyatt Regency Hotel, 17900 Jamboree Road, Irvine, California.Save to My Web
Genzyme Launches New Diagnostic Test for Common Blood Cancer
RedNova - Jul 27 11:11 AM
CAMBRIDGE, Mass., July 27 /PRNewswire-FirstCall/ — Genzyme Corporation announced today the availability of its p53 Mutation Analysis for B-cell chronic lymphocytic leukemia (B-CLL). P53 is a tumor suppressor gene that stops cell division when DNA damage is present.Save to My Web
Older Americans choosing to ignore colorectal cancer
The Advocate - Jul 25 4:24 AM
WASHINGTON (AP) — It’s the cancer with the yuck factor, that part of the anatomy lots of people would rather ignore. And too many are ignoring it possibly to death: Nearly 42 million Americans over 50 years old aren’t getting checks for colorectal cancer, the nation’s No. 2 cancer killer.Save to My Web
Clinical trials in S’pore unveil encouraging results to treat colon cancer
Channel NewsAsia via Yahoo! Singapore News - Jul 27 7:17 AM
SINGAPORE : Early clinical trials at the National Cancer Centre have unveiled encouraging results for colon cancer sufferers.Save to My Web